These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7867699)

  • 21. [Calcitonin and paratirin in nodular pathology of the thyroid gland].
    Ivanov PK; Tkacheva GA; Telish VM; Karetnikov IuP
    Probl Endokrinol (Mosk); 1983; 29(1):27-30. PubMed ID: 6835952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
    Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
    Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of angiogenic growth factors in patients with thyroid gland tumors and parathyroid adenoma.
    Veselý D; Astl J; Matucha P; Sterzl I; Betka J
    Neuro Endocrinol Lett; 2003 Dec; 24(6):417-9. PubMed ID: 15073567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
    Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
    Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thyroglobulin (Tg) in normal subjects and patients with thyroid diseases].
    Pineda G; Gallardo E; Cáceres E; Aguayo J
    Rev Med Chil; 1982 Nov; 110(11):1097-100. PubMed ID: 7184098
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
    Takami H; Shikata J; Ozaki O; Mimura T; Ito K
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Katacalcin: a new plasma calcium-lowering hormone.
    Hillyard CJ; Myers C; Abeyasekera G; Stevvensvenson JC; Craig RK; MacIntyre I
    Lancet; 1983 Apr; 1(8329):846-8. PubMed ID: 6132180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease.
    Torrigiani G; Doniach D; Roitt IM
    J Clin Endocrinol Metab; 1969 Mar; 29(3):305-14. PubMed ID: 5773064
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioimmunoassay for calcitonin gene-related peptide and its measurement in sera of patients with thyroid disease.
    Yoshida H; Hamada N; Noh J; Ito K; Morii H
    Endocrinol Jpn; 1992 Feb; 39(1):81-91. PubMed ID: 1376685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C cell adenoma of the thyroid: a rare but distinct clinical entity.
    Kodama T; Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M; Hirayama A
    Surgery; 1988 Dec; 104(6):997-1003. PubMed ID: 3194851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmon and human calcitonin-like peptides in man.
    Tobler PH; Tschopp FA; Dambacher MA; Fischer JA
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):253-9. PubMed ID: 6723077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Katacalcin--a new tumor marker in C-cell cancer of the thyroid gland].
    Raue F; Boden M; Girgis S; Rix E; Ziegler R
    Klin Wochenschr; 1987 Jan; 65(2):82-6. PubMed ID: 3550267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcitonin--interpretation of the test results].
    Morii H
    Nihon Rinsho; 1973; 31():1700-4. PubMed ID: 4582275
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
    Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
    Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies.
    Seth R; Motté P; Kehely A; Wimalawansa SJ; Self CH; Bellet D; Bohuon C; MacIntyre I
    J Endocrinol; 1988 Nov; 119(2):351-7. PubMed ID: 3058855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.